Acute idiopathic maculopathy after COVID-19 vaccination.

Authors :: Hasegawa T
Sannomiya Y
Toyoda M
Maruko I
Iida T
Source :: American journal of ophthalmology case reports [Am J Ophthalmol Case Rep] 2022 Jun; Vol. 26, pp. 101479. Date of Electronic Publication: 2022 Mar 09.
Publication Year :: 2022
Abstract: Purpose: We report a case of acute idiopathic maculopathy (AIM) that developed after COVID-19 vaccination.<br />Observations: A 54-year-old woman complained of a sudden decrease of visual acuity in her right eye one day after receiving a second COVID-19 vaccination (Pfizer). Fundus photograph showed a circular yellow lesion at the fovea in right eye. Optical coherence tomography revealed the thickening of retinal pigment epithelium and the presence of subretinal fluid. Three months after the initial visit, the BCVA and the fundus images had favorable recovery in the right eye.<br />Conclusions and Importance: We describe a case of AIM after receiving COVID-19 vaccination. These findings may be a helpful in understanding the pathogenesis of AIM.<br />Competing Interests: The following authors have no financial disclosures: Y.S, M.T. T.H received grant support from Novartis Pharma K.K., Bayer, and Santen; I.M received grant support from Novartis Pharma K.K., Bayer, Santen, Nidek, and Senju; T.I received grant support from Novartis Pharma K.K., Bayer, Santen, Nidek, Senju, and Otsuka.<br /> (© 2022 Published by Elsevier Inc.)